Notably, high-BSG expression was sensitive to 12 (e.g., KPT-8602 and brigatinib) of the 57 drugs (Figure 9B), suggesting the potential of these drugs in treating cancer patients with elevated BSG expression. This evidence concerns the gene BSG and cancer.